The impact of medication adherence on coronary artery disease costs and outcomes: A systematic review

American Journal of Medicine

Volumn 126, Issue 4, 2013, Pages

  Bitton, Asaf ^a,b   Choudhry, Niteesh K ^a   Matlin, Olga S ^c   Swanton, Kellie ^a   Shrank, William H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CVS Caremark   (United States)

Author keywords

Coronary artery disease; Costs; Medication adherence; Outcomes; Pharmacoeconomics; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE PLUS ATORVASTATIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PROPRANOLOL; THIENOPYRIDINE DERIVATIVE;

ANTIHYPERTENSIVE THERAPY; CORONARY ARTERY DISEASE; COST CONTROL; COST OF ILLNESS; DRUG COST; HEALTH BEHAVIOR; HEALTH CARE COST; HEART VENTRICLE EXTRASYSTOLE; HUMAN; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEWCASTLE OTTAWA SCORING SCALE; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; SYSTEMATIC REVIEW;

EID: 84875193118     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.09.004     Document Type: Article

References (33)

1. P.A. Heidenreich, J.G. Trogdon, O.A. Khavjou Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association Circulation 123 8 2011 933 944
2. M.R. DiMatteo, P.J. Giordani, H.S. Lepper, T.W. Croghan Patient adherence and medical treatment outcomes: a meta-analysis Med Care 40 9 2002 794 811
3. M. Salas, D. Hughes, A. Zuluaga Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature Value Health 12 6 2009 915 922
4. M.C. Roebuck, J.N. Liberman, M. Gemmill-Toyama, T.A. Brennan Medication adherence leads to lower health care use and costs despite increased drug spending Health Aff (Millwood) 30 1 2011 91 99
5. C. Bechtel, D.L. Ness If you build it, will they come? Designing truly patient-centered health care Health Aff (Millwood) 29 5 2010 914 920
6. M.H. Bouchard, A. Dragomir, L. Blais Impact of adherence to statins on coronary artery disease in primary prevention Br J Clin Pharmacol 63 6 2007 698 708
7. N.S. Breekveldt-Postma, F.J. Penning-van Beest, S.J. Siiskonen The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke Curr Med Res Opin 24 1 2008 121 127
8. G. Corrao, V. Conti, L. Merlino Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy Clin Ther 32 2 2010 300 310
9. D.G. Pittman, W. Chen, S.J. Bowlin, J.M. Foody Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations Am J Cardiol 107 11 2011 1662 1666
10. S. Perreault, A. Dragomir, L. Blais Impact of better adherence to statin agents in the primary prevention of coronary artery disease Eur J Clin Pharmacol 65 10 2009 1013 1024
11. A.P. Amin, E. Mukhopadhyay, S. Nathan Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population Transl Res 154 2 2009 78 89
12. R.E. Aubert, J. Yao, F. Xia, S.B. Garavaglia Is there a relationship between early statin compliance and a reduction in healthcare utilization? Am J Manag Care 16 6 2010 459 466
13. R.H. Chapman, J. Yeaw, C.S. Roberts Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees BMC Cardiovasc Disord 10 2010 29
14. N.K. Choudhry, J. Avorn, R.J. Glynn Full coverage for preventive medications after myocardial infarction N Engl J Med 365 22 2011 2088 2097
15. G. Corrao, A. Parodi, F. Nicotra Better compliance to antihypertensive medications reduces cardiovascular risk J Hypertens 29 3 2011 610 618
16. E.J. Gallagher, C.M. Viscoli, R.I. Horwitz The relationship of treatment adherence to the risk of death after myocardial infarction in women JAMA 270 6 1993 742 744
17. A.K. Gehi, S. Ali, B. Na, M.A. Whooley Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study Arch Intern Med 167 16 2007 1798 1803
18. P.M. Ho, J.A. Spertus, F.A. Masoudi Impact of medication therapy discontinuation on mortality after myocardial infarction Arch Intern Med 166 17 2006 1842 1847
19. P.M. Ho, D.J. Magid, S.M. Shetterly Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease Arch Intern Med 168 3 2008 271 276
20. P.M. Ho, D.J. Magid, S.M. Shetterly Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease Am Heart J 155 4 2008 772 779
21. J. Irvine, B. Baker, J. Smith Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Psychosom Med 61 4 1999 566 575
22. S.A. Kleiner, W.B. Vogt, P. Gladowski Beta-blocker compliance, mortality, and reinfarction: validation of clinical trial association using insurer claims data Am J Med Qual 24 6 2009 512 519
23. L.K. Newby, N.M. LaPointe, A.Y. Chen Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease Circulation 113 2 2006 203 212
24. D.G. Pittman, Z. Tao, W. Chen, G.D. Stettin Antihypertensive medication adherence and subsequent healthcare utilization and costs Am J Manag Care 16 8 2010 568 576
25. J.N. Rasmussen, A. Chong, D.A. Alter Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction JAMA 297 2 2007 177 186
26. V. Shalev, G. Chodick, H. Silber Continuation of statin treatment and all-cause mortality: a population-based cohort study Arch Intern Med 169 3 2009 260 268
27. J.A. Spertus, R. Kettelkamp, C. Vance Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 24 2006 2803 2809
28. S.X. Sun, X. Ye, K.Y. Lee Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction Clin Ther 30 Pt 2 2008 2217 2227
29. L. Wei, J. Wang, P. Thompson Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study Heart 88 3 2002 229 233
30. A. Dragomir, R. Cote, M. White Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting Value Health 13 1 2010 87 94
31. C.R. Dormuth, A.R. Patrick, W.H. Shrank Statin adherence and risk of accidents: a cautionary tale Circulation 119 15 2009 2051 2057
32. J.P. Piccini, J.S. Berger, C.M. O'Connor Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials Eur Heart J 30 10 2009 1245 1253
33. L. Goldman, A.M. Epstein Improving adherence-money isn't the only thing N Engl J Med 365 22 2011 2131 2133